Open Insider Trading Activity for Candel Therapeutics, Inc. Chief Executive Officer Tak Paul Peter
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction CADL | 2026-09-11 | 2026-09-11 | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | Sell | 2 | 280,245 | $11.28 | $3,160,783.32 | 49.49% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting CADL | 2025-01-17 | 2025-01-15 | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | Sell | 1 | 21,704 | $7.23 | $156,919.92 | 7.93% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting CADL | 2025-01-10 | 2025-01-08 | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | Sell | 1 | 21,172 | $8.22 | $174,033.84 | 7.18% | View Filing |